文献速递先天性心脏病外科心外重症与机械循环支持

单心室生理患儿心室辅助装置支持策略的演变

Evolution of Ventricular Assist Device Support Strategy in Children With Univentricular Physiology.
PubMed 文献 · Ann Thorac Surg · 2021-10-26

本研究回顾了2012年3月至2020年4月期间18例单心室生理患儿接受心室辅助装置(VAD)支持的经验,作为决策、移植或恢复的桥接。结果显示,39%的患儿接受移植,11%恢复,50%在出院前死亡;33%发生神经损伤。结论认为,通过合适的患者选择和特定的插管策略,单心室患儿包括新生儿可以成功桥接到目标终点。

要点

  • 单心室患儿VAD支持可作为移植或恢复的桥接,但死亡率较高。
  • 需注意神经损伤并发症,本组发生率为33%。
  • 特定插管策略和患者选择对成功桥接至关重要。

核心结论

  • 单心室患儿包括新生儿,通过适当的患者选择和特定插管策略,可以成功桥接到期望的终点。

研究设计与样本

  • 回顾性研究,纳入2012年3月至2020年4月期间18例单心室生理接受VAD支持的患儿,排除短期支持者。

主要发现

  • 18例中,连续流装置13例(72%),搏动流装置5例(28%)。
  • 7例(39%)接受移植,2例(11%)恢复,9例(50%)出院前死亡。
  • 6例(33%)发生神经损伤;末次随访时9例(50%)存活,中位时间1.2年(IQR 0.8-4.3)。

临床怎么用

  • 对于单心室生理需要VAD支持的患儿,可考虑个体化插管策略和患者选择以实现桥接目标。

以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。

原文

BACKGROUND: Since 2012, we have supported 18 children with single ventricle (SV) physiology on ventricular assist devices (VADs) as a bridge to decision, transplantation, or recovery. We provide a detailed report of our cumulative surgical experience and lessons learned from these patients. METHODS: We reviewed all SV-VADs between March 2012 and April 2020. Implanted SV-VADs intended for short-term support were excluded. Demographic and clinical data included palliation stage at the time of VAD implantation, cannulation configuration, device type, duration of support, circuit and device interventions, postoperative support, anticoagulation strategy, complications, mortality, and 1-year survival postdischarge. RESULTS: Five SV newborns without prior surgical palliation, 8 infants post-Norwood/hybrid procedure, 4 infants post-Glenn, and 1 infant post-Fontan were initially supported with either continuous-flow (n = 13 of 18, 72%) or pulsatile-flow (n = 5 of 18, 28%) devices. Three (17%) of 18 transitioned to another device during support. Before VAD conversion, 9 (50%) of 18 were supported by extracorporeal membrane oxygenation. Outcomes included 7 (39%) of 18 who transplanted, 2 (11%) of 18 who recovered, and 9 (50%) of 18 who died before discharge. Of these deaths, 2 occurred after transplantation and 2 after explantation, and 5 had redirection of care while on support secondary to previously undiagnosed pulmonary venoocclusive disease (n = 2) or severe neurologic events (n = 3). Overall, 6 (33%) of 18 experienced neurologic injury. At last follow-up, 9 (50%) of 18 children were alive (median 1.2 [interquartile range, 0.8-4.3] years postexplantation/transplantation). CONCLUSIONS: Our experience shows that SV children, including newborns, can be successfully bridged to desired endpoints with proper patient selection and using specific cannulation strategies. Continuing utilization of this strategy is warranted for future children requiring VAD support.

来源:Ann Thorac Surg,查看原文。版权归原作者所有。

引用

  1. Merritt T, Gazit AZ, Carvajal H, et al. Evolution of Ventricular Assist Device Support Strategy in Children With Univentricular Physiology. Ann Thorac Surg. 2021. PMID: 34710386. doi:10.1016/j.athoracsur.2021.09.043

供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。